Drug Shortage Report for RECOMBIVAX HB
Report ID | 873 |
Drug Identification Number | 02243676 |
Brand name | RECOMBIVAX HB -(PRESERVATIVE FREE) |
Common or Proper name | (hepatitis B vaccine [recombinant]) |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
Strength(s) | 10MCG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 10MCG/1ML 10X1DOSE VIAL |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-08-01 |
Actual start date | 2017-08-04 |
Estimated end date | 2022-06-30 |
Actual end date | 2022-06-22 |
Shortage status | Resolved |
Updated date | 2022-06-23 |
Company comments | Format 1DOSE VIAL remains available. / Le format 1DOSE VIAL est encore disponible. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2017-03-13 | French | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |